Page 137 - Read Online

Page 177 De Robertis et al. Art Int Surg 2023;3:166-79 https://dx.doi.org/10.20517/ais.2023.18

carcinoma undergoing drug-eluting bead transarterial chemoembolization (DEB-TACE) using biphasic contrast-enhanced ct image
data: correlation with liver perfusion CT. Acad Radiol 2017;24:1352-63. DOI
28. Wu LF, Rao SX, Xu PJ, et al. Pre-TACE kurtosis of ADC total derived from histogram analysis for diffusion-weighted imaging is the
best independent predictor of prognosis in hepatocellular carcinoma. Eur Radiol 2019;29:213-23. DOI
29. Shaghaghi M, Aliyari Ghasabeh M, Ameli S, et al. Post-TACE changes in ADC histogram predict overall and transplant-free survival
in patients with well-defined HCC: a retrospective cohort with up to 10 years follow-up. Eur Radiol 2021;31:1378-90. DOI
30. Yang X, Yuan C, Zhang Y, Li K, Wang Z. Predicting hepatocellular carcinoma early recurrence after ablation based on magnetic
resonance imaging radiomics nomogram. Medicine 2022;101:e32584. DOI PubMed PMC
31. Fiz F, Jayakody Arachchige VS, Gionso M, et al. Radiomics of biliary tumors: a systematic review of current evidence. Diagnostics
2022;12:826. DOI PubMed PMC
32. Liu X, Khalvati F, Namdar K, et al. Can machine learning radiomics provide pre-operative differentiation of combined hepatocellular
cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma to inform optimal treatment planning? Eur Radiol
2021;31:244-55. DOI
33. Zhou C, Wang Y, Ma L, Qian X, Yang C, Zeng M. Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated
with tumor biomarkers and prognosis. Eur Radiol 2022;32:78-88. DOI
34. Ji GW, Zhu FP, Zhang YD, et al. A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic
cholangiocarcinoma. Eur Radiol 2019;29:3725-35. DOI
35. Chu H, Liu Z, Liang W, et al. Radiomics using CT images for preoperative prediction of futile resection in intrahepatic
cholangiocarcinoma. Eur Radiol 2021;31:2368-76. DOI
36. Qin H, Hu X, Zhang J, et al. Machine-learning radiomics to predict early recurrence in perihilar cholangiocarcinoma after curative
resection. Liver Int 2021;41:837-50. DOI
37. Groot Koerkamp B, Wiggers JK, Allen PJ, et al. American joint committee on cancer staging for resected perihilar
cholangiocarcinoma: a comparison of the 6th and 7th editions. HPB 2014;16:1074-82. DOI PubMed PMC
38. Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann
Surg 2001;234:507-19. DOI PubMed PMC
39. Gazzaniga GM, Faggioni A, Filauro M. Surgical treatment of proximal bile duct tumors. Int Surg 1985;70:45-8. PubMed
40. Park HJ, Park B, Park SY, et al. Preoperative prediction of postsurgical outcomes in mass-forming intrahepatic cholangiocarcinoma
based on clinical, radiologic, and radiomics features. Eur Radiol 2021;31:8638-48. DOI
41. Zhang J, Wu Z, Zhao J, et al. Intrahepatic cholangiocarcinoma: MRI texture signature as predictive biomarkers of immunophenotyping
and survival. Eur Radiol 2021;31:3661-72. DOI
42. Mosconi C, Cucchetti A, Bruno A, et al. Radiomics of cholangiocarcinoma on pretreatment CT can identify patients who would best
respond to radioembolisation. Eur Radiol 2020;30:4534-44. DOI
43. Fiz F, Viganò L, Gennaro N, et al. Radiomics of liver metastases: a systematic review. Cancers 2020;12:2881. DOI PubMed PMC
44. Wesdorp NJ, van Goor VJ, Kemna R, et al. Advanced image analytics predicting clinical outcomes in patients with colorectal liver
metastases: a systematic review of the literature. Surg Oncol 2021;38:101578. DOI
45. Jia LL, Zhao JX, Zhao LP, Tian JH, Huang G. Current status and quality of radiomic studies for predicting KRAS mutations in
colorectal cancer patients: a systematic review and meta-analysis. Eur J Radiol 2023;158:110640. DOI PubMed
46. Kelahan LC, Kim D, Soliman M, et al. Role of hepatic metastatic lesion size on inter-reader reproducibility of CT-based radiomics
features. Eur Radiol 2022;32:4025-33. DOI
47. Ahn SJ, Kim JH, Park SJ, Han JK. Prediction of the therapeutic response after FOLFOX and FOLFIRI treatment for patients with liver
metastasis from colorectal cancer using computerized CT texture analysis. Eur J Radiol 2016;85:1867-74. DOI PubMed
48. Dercle L, Lu L, Schwartz LH, et al. Radiomics response signature for identification of metastatic colorectal cancer sensitive to
therapies targeting EGFR pathway. J Natl Cancer Inst 2020;112:902-12. DOI PubMed PMC
49. Dohan A, Gallix B, Guiu B, et al. Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in
patients with colorectal cancer treated with FOLFIRI and bevacizumab. Gut 2020;69:531-9. DOI
50. Creasy JM, Midya A, Chakraborty J, et al. Quantitative imaging features of pretreatment CT predict volumetric response to
chemotherapy in patients with colorectal liver metastases. Eur Radiol 2019;29:458-67. DOI PubMed PMC
51. Abunahel BM, Pontre B, Kumar H, Petrov MS. Pancreas image mining: a systematic review of radiomics. Eur Radiol 2021;31:3447-
67. DOI PubMed
52. Gao Y, Cheng S, Zhu L, et al. A systematic review of prognosis predictive role of radiomics in pancreatic cancer: heterogeneity
markers or statistical tricks? Eur Radiol 2022;32:8443-52. DOI PubMed
53. Staal FCR, Aalbersberg EA, van der Velden D, et al. GEP-NET radiomics: a systematic review and radiomics quality score
assessment. Eur Radiol 2022;32:7278-94. DOI
54. Goggins M, Overbeek KA, Brand R, et al. Management of patients with increased risk for familial pancreatic cancer: updated
recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut 2020;69:7-17. DOI PubMed
PMC
55. Signoretti M, Bruno MJ, Zerboni G, Poley JW, Delle Fave G, Capurso G. Results of surveillance in individuals at high-risk of
pancreatic cancer: a systematic review and meta-analysis. United Eur Gastroent J 2018;6:489-99. DOI PubMed PMC
56. Paiella S, Capurso G, Cavestro GM, et al. Results of first-round of surveillance in individuals at high-risk of pancreatic cancer from the